Blog
RSS FeedPosted by Michael Wonder on 26 Feb 2019
They can’t get their medicines. So they’re moving to Scotland.
26 February 2019 - Families in England are preparing to leave the country in a desperate bid to obtain a cystic ...
Posted by Michael Wonder on 25 Feb 2019
Family fight for cancer treatment in USA because drugs not available in UK
25 February 2019 - A mother of four from Downham Market in west Norfolk says she won't live to 50 ...
Posted by Michael Wonder on 18 Feb 2019
Brexit: will Britons living in the EU still get health care?
18 February 2019 - If the UK leaves the EU without a deal, reciprocal health care arrangements will not automatically ...
Posted by Michael Wonder on 15 Feb 2019
EU, America and China will all get new medicines ahead of Britain after Brexit, drug company boss warns
14 February 2019 - David Meek, the CEO of Ipsen, warns Britain leaving the European Union has seen the country fall ...
Posted by Michael Wonder on 14 Feb 2019
Cystic fibrosis breakthrough: hope for British sufferers as life-saving drug talks resume
14 February 2019 - Britain's cystic fibrosis sufferers have received fresh hope of receiving a life-saving drug after officials agreed to ...
Posted by Michael Wonder on 07 Feb 2019
What will a no-deal Brexit mean for pharma and health care?
7 February 2019 - Britons are bracing themselves for the UK’s imminent departure from the European Union. A worst-case scenario ...
Posted by Michael Wonder on 04 Feb 2019
UK patient activist group takes aim at Orkambi patent
4 February 2019 - Calls to bypass patent adds to pressure on Vertex. ...
Posted by Michael Wonder on 04 Feb 2019
Mother of four is denied cancer drug that could save her life
2 February 2019 - A British nurse with four children is being denied potentially life-saving cancer treatment that was approved ...
Posted by Michael Wonder on 04 Feb 2019
Calls for action on patients denied £100,000 cystic fibrosis drug
4 February 2019 - Ministers urged to consider revoking patent on life-extending Orkambi, which NHS cannot afford. ...
Posted by Michael Wonder on 23 Jan 2019
Vertex’s CF drug gets label extension as pricing row continues Vertex’s CF drug gets label extension as pricing row continues
23 January 2019 - While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug ...
Posted by Michael Wonder on 21 Jan 2019
NHS England sees off AbbVie's hepatitis C legal challenge
21 January 2019 - Claims of unfair process dismissed by High Court. ...
Posted by Michael Wonder on 02 Jan 2019
NHS England to fund Actelion's Uptravi
2 January 2019 - Actelion has announced that NHS patients in England, who have the rare, incurable and devastating disease ...
Posted by Michael Wonder on 02 Jan 2019
NHS to fund Afinitor for TSC-related epilepsy
2 January 2019 - NHS England has announced that from April this year it will fund Novartis' Afinitor (everolimus) for ...
Posted by Michael Wonder on 10 Dec 2018
NICE turns down Opdivo/Yervoy combo for kidney cancer
10 December 2018 - NICE has published draft guidelines rejecting NHS funds for Opdivo/Yervoy for untreated metastatic renal cell carcinoma. ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...